Overview

Study of Enzyme Supplements to Treat Celiac Disease

Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine whether a cocktail of two common food-grade enzyme supplements leads to decrease of serum activity markers in celiac disease patients insufficiently treated by previous gluten exclusion.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Heim Pal Children's Hospital
Collaborator:
Stanford University